Bayer: Sales and earnings increased

Covestro deconsolidated / Group sales grow by 1.2 percent (Fx& portfolio adj.) to EUR 8,025 million / EBITDA before special items up by 4.1 percent to EUR 2,204 million / Sales and earnings growth at Pharmaceuticals / Consumer Health business weak, as expected / Sales gains at Crop Science and Animal Health / Net income of EUR 3,881 million including Covestro book profit / Core earnings per share at EUR 1.47 (minus 3.9 percent) / Group outlook for 2017 confirmed based on change in structure
Source: Bayer Company News - Category: Pharmaceuticals Source Type: news